GT
JAZZ icon

Glenview Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Glenview Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Hold
4,409
– – 0.01% 287
2026
Q1 		$834K Hold
4,409
– – 0.01% 308
2025
Q4 		$750K Hold
4,409
– – 0.01% 315
2025
Q3 		$581K Sell
4,409
-3
-0.1% -$360 0.01% 356
2025
Q2 		$468K Buy
4,412
+263
+6% +$28.6K 0.01% 383
2025
Q1 		$515K Hold
4,149
– – 0.01% 356
2024
Q4 		$511K Sell
4,149
-500
-11% -$58.9K 0.01% 352
2024
Q3 		$518K Hold
4,649
– – 0.01% 356
2024
Q2 		$496K Buy
4,649
+675
+17% +$74.2K 0.01% 349
2024
Q1 		$479K Buy
3,974
+1,448
+57% +$177K 0.01% 352
2023
Q4 		$311K Buy
2,526
+288
+13% +$35.9K 0.01% 396
2023
Q3 		$290K Buy
+2,238
New +$298K 0.01% 386
2023
Q1 		– Sell
-1,315
Closed -$209K – 448
2022
Q4 		$209K Buy
+1,315
New +$193K 0.01% 416
2021
Q4 		– Sell
-2,875
Closed -$375K – 425
2021
Q3 		$375K Hold
2,875
– – 0.01% 311
2021
Q2 		$511K Buy
2,875
+850
+42% +$147K 0.02% 264
2021
Q1 		$333K Buy
+2,025
New +$333K 0.01% 322

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Glenview Trust's JAZZ Position: Q2 2026 in Review

Glenview Trust held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 4,409 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #287.

Glenview Trust first reported a position in JAZZ in Q1 2021 and has held it in 16 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Glenview Trust held 4,409 shares of Jazz Pharmaceuticals worth $1.06M as of Q2 2026.
  • Glenview Trust left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #287 holding.
  • Glenview Trust first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 16 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.